EDP-001

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameEDP-001
Drug Alias NameEDP001EDP-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Tetraspecific monoclonal antibody
Mechanisms of ActionAnti-CD3Anti-CD19Anti-BCMA
TargetsT cell surface glycoprotein CD3B-lymphocyte antigen CD19B-cell maturation protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEdding Genor Group Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEdding Genor Group Holdings Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A